Therapeutic Role of Tangshenkang Granule (糖肾康颗粒) in Rat Model with Diabetic Nephropathy

Shun-jin Hu; Bing Shu; Hua Jin; Xiao-feng Li; Jia-rong Mao; Ke-jun Ren; Lei Gao; Li Yang; You-wan Wu; Yong-jun Wang

doi:10.1007/s11655-016-2607-x

Your Location：

Home >

Browse articles >

Therapeutic Role of Tangshenkang Granule (糖肾康颗粒) in Rat Model with Diabetic Nephropathy

Updated：2021-08-27

- Therapeutic Role of Tangshenkang Granule (糖肾康颗粒) in Rat Model with Diabetic Nephropathy
- Chinese Journal of Integrative Medicine Vol. 24, Issue 8, Pages: 600-605(2018)
- Affiliations：
  
  1. Department of Internal Medicine, the First Affiliated Hospital of Anhui University of Traditional Chinese Medicine,Hefei,China
  2. Department of Orthopaedics, Longhua Hospital, Shanghai University of Traditional Chinese Medicine,Shanghai,China
  3. Spine Research Institute, Shanghai University of Traditional Chinese Medicine,Shanghai,China
  4. Department of Pathology, Shanxi Hospital of Traditional Chinese Medicine,Xi’an,China
  5. Graduate School, Anhui University of Traditional Chinese Medicine,Hefei,China
- Author bio：
- Funds：
  
  Supported by the Scientific Research Project of Colleges and Universities in Anhui Province, China (No. 2013z172) and the National Natural Science Foundation of China (No. 81503590)
- DOI：10.1007/s11655-016-2607-x
  CLC：
- Published：2018，
  
  Published Online：24 October 2016，
Scan for full text
Hu, Sj., Shu, B., Jin, H. et al. Therapeutic Role of Tangshenkang Granule (糖肾康颗粒) in Rat Model with Diabetic Nephropathy., Chin. J. Integr. Med. 24, 600–605 (2018). https://doi.org/10.1007/s11655-016-2607-x

Shun-jin Hu, Bing Shu, Hua Jin, et al. Therapeutic Role of Tangshenkang Granule (糖肾康颗粒) in Rat Model with Diabetic Nephropathy. [J]. Chinese Journal of Integrative Medicine 24(8):600-605(2018)
Hu, Sj., Shu, B., Jin, H. et al. Therapeutic Role of Tangshenkang Granule (糖肾康颗粒) in Rat Model with Diabetic Nephropathy., Chin. J. Integr. Med. 24, 600–605 (2018). https://doi.org/10.1007/s11655-016-2607-x DOI：

Shun-jin Hu, Bing Shu, Hua Jin, et al. Therapeutic Role of Tangshenkang Granule (糖肾康颗粒) in Rat Model with Diabetic Nephropathy. [J]. Chinese Journal of Integrative Medicine 24(8):600-605(2018) DOI： 10.1007/s11655-016-2607-x.

摘要

To evaluate the renal protective effect of Tangshenkang Granule (糖肾康颗粒) in a rat model of diabetic nephropathy (DN). Forty male Sprague-Dawley rats were randomly divided into control

Tangshenkang and benazepril groups. DN model was established in the rats of DN

Tangshenkang and benazepril groups. Tangshenkang Granule solution and benazepril hydrochloride solution were intragastrically administered daily to the rats in the Tangshenkang and benazepril groups for 8 weeks

respectively. Urinary albumin and creatinine were detected. The albumin/creatinine (ACR) was calculated in addition to 24 h urinary protein (24-h UPr)

serum creatinine (Scr)

blood urea nitrogen (BUN)

total cholesterol (TC)

triglyceride (TG)

low-density lipoprotein (LDL)

high-density lipoprotein (HDL)

and creatinine clearance rate (Ccr). Right kidneys were harvested for pathological observation using periodic acid-silver methenamine-Masson staining. The average glomerular diameter (DG)

average glomerular (AG) and mesangial areas (AM) were measured. The thickness of glomerular basement membrane (TGBM) was detected using transmission electron microscope. Compared with rats in the control group

rats in the DN group showed significantly decreased body weight

increased hypertrophy index

24-h urinary volume

24-h UPr

ACR

Scr

BUN

Ccr

blood lipids as well as renal pathological indices including DG

AM/AG and TGBM (P <0.05). Compared with the DN group

the weights of rats in the Tangshenkang and benazepril groups were significantly increased

and the renal hypertrophy indices were significantly decreased (P <0.05). The 24-h urinary volumes

ACR

24-h UPr

Scr

BUN

Ccr

LDL

AM and TGBM were obviously decreased (P <0.05). Compared with the benazepril group

the Tangshenkang group showed significantly decreased levels of ACR

24-h UPr

AG and AM (P <0.05). Tangshenkang Granule decreased the urinary protein

attenuated the high glomerular filtration rate and improved lipid metabolism in DN rats

and prevented further injury induced by diabetic nephropathy.

Abstract

To evaluate the renal protective effect of Tangshenkang Granule (糖肾康颗粒) in a rat model of diabetic nephropathy (DN). Forty male Sprague-Dawley rats were randomly divided into control

Tangshenkang and benazepril groups. DN model was established in the rats of DN

respectively. Urinary albumin and creatinine were detected. The albumin/creatinine (ACR) was calculated in addition to 24 h urinary protein (24-h UPr)

serum creatinine (Scr)

blood urea nitrogen (BUN)

total cholesterol (TC)

triglyceride (TG)

low-density lipoprotein (LDL)

high-density lipoprotein (HDL)

and creatinine clearance rate (Ccr). Right kidneys were harvested for pathological observation using periodic acid-silver methenamine-Masson staining. The average glomerular diameter (DG)

rats in the DN group showed significantly decreased body weight

increased hypertrophy index

24-h urinary volume

24-h UPr

ACR

Scr

BUN

Ccr

blood lipids as well as renal pathological indices including DG

AM/AG and TGBM (P <0.05). Compared with the DN group

the weights of rats in the Tangshenkang and benazepril groups were significantly increased

and the renal hypertrophy indices were significantly decreased (P <0.05). The 24-h urinary volumes

ACR

24-h UPr

Scr

BUN

Ccr

LDL

AM and TGBM were obviously decreased (P <0.05). Compared with the benazepril group

the Tangshenkang group showed significantly decreased levels of ACR

24-h UPr

AG and AM (P <0.05). Tangshenkang Granule decreased the urinary protein

attenuated the high glomerular filtration rate and improved lipid metabolism in DN rats

and prevented further injury induced by diabetic nephropathy.

关键词

diabetic nephropathyTangshenkang Granulekidney functionlipid metabolismkidney pathologyChinese Medicine

Keywords

diabetic nephropathyTangshenkang Granulekidney functionlipid metabolismkidney pathologyChinese Medicine

references

Zhang LX, Wang HY. Study on the trends and countermeasures of diabetic nephropathy in China from the perspective of epidemiology. Chin J Intern Med (Chin) 2010;49:804–805.

Lv Y, Wang YP, Cao EZ, Zhang L, Ren KJ. The study on the effect of Tangshenkang Granule on renal damage in diabetic nephropathy. J New Chin Med (Chin) 2006;38:44–45.

Wang L, Yu SJ. The experimental study on the method of preparing the model of type 2 diabetic nephropathy rats. Liaoning J Tradit Chin Med (Chin) 2011;38:1675–1677.

Yang YB, Zhang W, Su KL, Chen ZJ, Huang SM. Study on experimental diabetic nephropathy in rats induced by streptoeotocin. West China Med J (Chin) 2005;20:299–300.

Zhang JF, Meng M. Determination of polysaccharide in Tangshenkang Granules by itraviolet spectrophotometryl. J Anhui Univ Chin Med (Chin) 2005;24:48–49.

Chen Q, ed. Chinese medicine pharmacology research methodology. Beijing: People’s Medical Publishing House; 1993:1103.

Shi SS, Zhang YQ, Wen WB. Effects of liver ? receptor expression on rats with diabetic nephropathy and its mechanism. Chin Gen Pract (Chin) 2015;18:1029–1031.

Cheng H, Dong HR, Lin RQ, Sun LJ, Chen YP. Determination of normal value of glomerular size in Chinese adults by different measurement methods. Nephrology (Carlton) 2012;17:488–492.

Zou WZ, ed. Pathology of renal biopsy. Beijing: Peking University Medical Press; 2014:160-162.

Giunti S, Barit D, Cooper ME. Mechanisms of diabetic nephropathy role of hypertension. Hypertension 2006;48:519–526.

Qi D, Xing Y, Zhang Y, Lu WR, Fan HY. The Protective effect of salvianolate combined with benazepril on diabetic nephropathy in streptozotocin-induced diabetic rats. Chin J Integr Tradit West Nephrol (Chin) 2012;13:314–316.

Xing SL, Zheng JF, Huang WZ. The study on diabetic nephropathy model in unilateral nephrectomy rats inducede by STZ. J Emerg Tradit Chin Med (Chin) 2006:15:643-644.

Song EF, Liu JJ, Jia RH, Wei GL, Ren KM. The study on the establishment of rat model of type 2 diabetic nephropathy. The J Pract Med (Chin) 2007;23:2840–2842.

Cao EZ, Yu XY, Hu SJ, Wang YP, Cheng W, Fang Q, et al. The effects of Tangshenkang Granule on early renal lesions in experimental diabetic rats. J Emerg Tradit Chin Med (Chin) 2002;3:448–450.

Yan LY, Yang SY, Li XJ. Research progress of the control mechanisms of Astragalus polysaccharides on diabetic nephropathy. Med Recapitulate (Chin) 2012;18:1727–1729.

Tan CQ. The therapeutic effect of Chinese yam polysaccharides on diabetic nephropathy in rats. Chin J Appl Physiol (Chin) 2014;30:437–438.

Huang L, Xie SF, Zhang L. Effects of Rhizoma dioscorea polysaccharide on renal function and MCP-1 expression in kidney of diabetic nephropathy rats. Chin Trop Med (Chin) 2013;13:1456–1459.

Wang JF. New progress of pharmacological research of prince ginseng. Pract Pharm Clin Remed (Chin) 2013;16:333–334.

Yang GQ, Zhang J, Ding XH, Zhang SQ. Astragalus, prince edward and rats to mesangial cells MMP-2 and TIMP-2— the influence of mRNA expression. Chin J Integr Tradit West Nephrol (Chin) 2011;12:673–675.

Gu LB, Wang YG, Wan M. Research progress on molecular mechanisms of Rhubarb in the treatment of diabetic nephropathy. Chin J Chin Mater Med (Chin) 2003;28:703–705.

Zhao SR, Lu YW, Chen JL, Duan HF, Wu ZZ. Experimental study on the hypoglycemic activity of catalpol from Rehmannia glutinosa Libosch. Lishizhen Med Mater Med Res (Chin) 2009;20:171–172.

Lu WB, Yang PJ, Li SM, Lu YP, Huang ZY, Huang H. Effect of salvianolate on inflammatory cytokines and renal vascular endothelial function in early diabetic nephropathy. Chin J Exp Tradit Med Form (Chin) 2014;20:184–187.

Liu DL, Ma ST. Research progress on pharmacological effects of total glucosides of paeony in the treatment of diabetic nephropathy. Chin J Integr Tradit West Med (Chin) 2013;33:1143–1146.

FULL TEXT LINK

More>

Views

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Chinese Medicine for Treating Diabetic Nephropathy

Panax notoginseng saponins protect kidney from diabetes by up-regulating silent information regulator 1 and activating antioxidant proteins in rats

Biotransformation effect of Bombyx Mori L. may play an important role in treating diabetic nephropathy

Protective Effects of Chaihu Shugan San (柴胡疏肝散) on Nonalcoholic Fatty Liver Disease in Rats with Insulin Resistance

Future view and development of immunology: Exploring the immunology based on Chinese medicine and culture

Related Author

No data

Related Institution

Department of Endocrinology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences

Department of Pathyology, Zhejiang Chinese Medical University

National Clinical Research Center of Traditional Chinese Medicine, Zhejiang Chinese Medical University

Department of Nephrology, Guangdong Provincial Hospital of Chinese Medicine

Guangzhou University of Chinese Medicine

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰